Sonoma Pharmaceuticals
SNOA
#9977
Rank
A$5.98 M
Marketcap
$4.47
Share price
2.46%
Change (1 day)
-18.58%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -A$7.04 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$12.69 Million. In 2023 the company made an earning of -A$6.82 Million, an increase over its 2022 earnings that were of -A$9.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$7.04 Million3.17%
2023 -A$6.82 Million-31.5%
2022 -A$9.96 Million16.86%
2021 -A$8.52 Million194.32%
2020 -A$2.9 Million-58.76%
2019 -A$7.02 Million-65.66%
2018 -A$20.44 Million4.84%
2017 -A$19.49 Million-2.17%
2016 -A$19.93 Million32.12%
2015 -A$15.08 Million-307.74%
2014 A$7.25 M-197.5%
2013 -A$7.45 Million
2010 -A$11.64 Million-14.02%
2009 -A$13.53 Million-57.28%
2008 -A$31.67 Million-8.03%
2007 -A$34.43 Million3.85%
2006 -A$33.16 Million39.31%
2005 -A$23.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$27.89 Million 291.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion 5,179.22%๐Ÿ‡บ๐Ÿ‡ธ USA